Calabrese C, Wang Y, Duggal A, Huang S, et al. Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised
Patients on B-Cell-Depleting Therapy With COVID-19: A Target Trial Emulation
Study. Clin Infect Dis 2025 Oct 24:ciaf521. doi: 10.1093.
PMID: 41132135
|